Pharmacodynamic (phase 0) study using etaracizumab in advanced melanoma.
Moschos SJ, Sander CA, Wang W, Reppert SL, Drogowski LM, Jukic DM, Rao UN, Athanassiou C, Buzoianu M, Mandic M, Richman L, McKinney L, Leininger J, Tice DA, Hammershaimb L, Kirkwood JM.
Moschos SJ, et al. Among authors: sander ca.
J Immunother. 2010 Apr;33(3):316-25. doi: 10.1097/CJI.0b013e3181c1f216.
J Immunother. 2010.
PMID: 20445352
Clinical Trial.